TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3094626
log Bayes Factor = 69.2155
Chromosome 6   position 30,323,623  (GRCh37) Explore rs3094626 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
1.000 0.000 0.000
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
K90.0 Coeliac disease
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
1.000 0.000 0.000
E03 Other hypothyroidism
1.000 0.000 0.000
E03.9 Hypothyroidism, unspecified
1.000 0.000 0.000
E10-E14 Diabetes mellitus
1.000 0.000 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.999 0.001 0.000
E05.9 Thyrotoxicosis, unspecified
0.998 0.002 0.000
E10.3 With ophthalmic complications
0.985 0.015 0.000
E10.2 With renal complications
0.947 0.053 0.000
E20-E35 Disorders of other endocrine glands
0.936 0.064 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.920 0.080 0.000
E27 Other disorders of adrenal gland
0.910 0.090 0.000
E27.1 Primary adrenocortical insufficiency
0.906 0.094 0.000
E14 Unspecified diabetes mellitus
0.884 0.116 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.868 0.132 0.000
E16 Other disorders of pancreatic internal secretion
0.862 0.138 0.000
E10.4 With neurological complications
0.850 0.150 0.000
E50-E64 Other nutritional deficiencies
0.819 0.181 0.000
E22 Hyperfunction of pituitary gland
0.811 0.189 0.000
E13 Other specified diabetes mellitus
0.808 0.192 0.000
E14.3 With ophthalmic complications
0.806 0.194 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.798 0.202 0.000
E06 Thyroiditis
0.798 0.202 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.794 0.206 0.000
E31 Polyglandular dysfunction
0.780 0.220 0.000
E03.8 Other specified hypothyroidism
0.779 0.221 0.000
K90 Intestinal malabsorption
0.762 0.238 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.759 0.241 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.754 0.246 0.000
E28 Ovarian dysfunction
0.752 0.248 0.000
E10.8 With unspecified complications
0.748 0.252 0.000
E10.1 With ketoacidosis
0.746 0.254 0.000
E55 Vitamin D deficiency
0.744 0.256 0.000
E14.1 With ketoacidosis
0.730 0.270 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.724 0.276 0.000
E10.6 With other specified complications
0.721 0.279 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.717 0.283 0.000
E00 Congenital iodine-deficiency syndrome
0.717 0.283 0.000
E03.5 Myxoedema coma
0.717 0.283 0.000
E03.4 Atrophy of thyroid (acquired)
0.717 0.283 0.000
E03.3 Postinfectious hypothyroidism
0.717 0.283 0.000
E12 Malnutrition-related diabetes mellitus
0.717 0.283 0.000
E05.5 Thyroid crisis or storm
0.716 0.284 0.000
E05.4 Thyrotoxicosis factitia
0.716 0.284 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.716 0.284 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.716 0.284 0.000
E14.8 With unspecified complications
0.713 0.287 0.000
E10.7 With multiple complications
0.705 0.295 0.000
E16.2 Hypoglycaemia, unspecified
0.702 0.298 0.000
E24 Cushing's syndrome
0.698 0.302 0.000
E55.9 Vitamin D deficiency, unspecified
0.690 0.310 0.000
E14.6 With other specified complications
0.680 0.320 0.000
E10.0 With coma
0.675 0.325 0.000
E05.8 Other thyrotoxicosis
0.673 0.327 0.000
E14.2 Withrenal complications
0.671 0.329 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.671 0.329 0.000
E32 Diseases of thymus
0.671 0.329 0.000
E30 Disorders of puberty, not elsewhere classified
0.671 0.329 0.000
E31.0 Autoimmune polyglandular failure
0.667 0.333 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.664 0.336 0.000
E03.1 Congenital hypothyroidism without goitre
0.660 0.340 0.000
E28.2 Polycystic ovarian syndrome
0.660 0.340 0.000
E15 Nondiabetic hypoglycaemic coma
0.659 0.341 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.658 0.342 0.000
E25 Adrenogenital disorders
0.658 0.342 0.000
E22.1 Hyperprolactinaemia
0.656 0.344 0.000
E20 Hypoparathyroidism
0.656 0.344 0.000
E06.3 Autoimmune thyroiditis
0.656 0.344 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.653 0.347 0.000
E27.5 Adrenomedullary hyperfunction
0.652 0.348 0.000
E27.0 Other adrenocortical overactivity
0.652 0.348 0.000
E27.2 Addisonian crisis
0.651 0.348 0.000
E58 Dietary calcium deficiency
0.638 0.362 0.000
E14.4 With neurological complications
0.637 0.362 0.000
E13.9 Without complications
0.637 0.363 0.000
E14.7 With multiple complications
0.634 0.366 0.000
E14.0 With coma
0.634 0.366 0.000
K90.9 Intestinal malabsorption, unspecified
0.632 0.368 0.000
E16.1 Other hypoglycaemia
0.624 0.376 0.000
E13.3 With ophthalmic complications
0.623 0.377 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.618 0.382 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.618 0.382 0.000
E16.4 Abnormal secretion of gastrin
0.618 0.382 0.000
E16.3 Increased secretion of glucagon
0.618 0.382 0.000
E26 Hyperaldosteronism
0.618 0.382 0.000
E06.5 Other chronic thyroiditis
0.616 0.384 0.000
E40-E46 Malnutrition
0.611 0.389 0.000
E23 Hypofunction and other disorders of pituitary gland
0.610 0.390 0.000
E14.5 With peripheral circulatory complications
0.599 0.400 0.000
E53 Deficiency of other B group vitamins
0.598 0.402 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.587 0.413 0.000
E63 Other nutritional deficiencies
0.587 0.413 0.000
E50 Vitamin A deficiency
0.587 0.413 0.000
E60 Dietary zinc deficiency
0.587 0.413 0.000
E59 Dietary selenium deficiency
0.587 0.413 0.000
E52 Niacin deficiency [pellagra]
0.587 0.413 0.000
E06.1 Subacute thyroiditis
0.584 0.416 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.582 0.418 0.000
E22.8 Other hyperfunction of pituitary gland
0.582 0.418 0.000
E13.8 With unspecified complications
0.579 0.421 0.000
E13.7 With multiple complications
0.579 0.421 0.000
E13.6 With other specified complications
0.579 0.421 0.000
E13.5 With peripheral circulatory complications
0.579 0.421 0.000
E13.4 With neurological complications
0.579 0.421 0.000
E13.2 With renal complications
0.579 0.421 0.000
E13.1 With ketoacidosis
0.579 0.421 0.000
E13.0 With coma
0.579 0.421 0.000
K75.4 Autoimmune hepatitis
0.574 0.426 0.000
E54 Ascorbic acid deficiency
0.573 0.427 0.000
E06.4 Drug-induced thyroiditis
0.572 0.428 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.572 0.428 0.000
E06.0 Acute thyroiditis
0.572 0.428 0.000
K90.8 Other intestinal malabsorption
0.570 0.430 0.000
E56 Other vitamin deficiencies
0.570 0.430 0.000
E51 Thiamine deficiency
0.561 0.439 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.560 0.440 0.000
E31.9 Polyglandular dysfunction, unspecified
0.559 0.441 0.000
E31.8 Other polyglandular dysfunction
0.559 0.441 0.000
E31.1 Polyglandular hyperfunction
0.559 0.441 0.000
E24.0 Pituitary-dependent Cushing's disease
0.559 0.441 0.000
E27.9 Disorder of adrenal gland, unspecified
0.548 0.452 0.000
K90.3 Pancreatic steatorrhoea
0.546 0.454 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.546 0.454 0.000
K90.1 Tropical sprue
0.546 0.454 0.000
E29 Testicular dysfunction
0.542 0.458 0.000
E28.9 Ovarian dysfunction, unspecified
0.539 0.461 0.000
E28.8 Other ovarian dysfunction
0.539 0.461 0.000
E28.1 Androgen excess
0.539 0.461 0.000
E28.0 Oestrogen excess
0.539 0.461 0.000
E55.0 Rickets, active
0.533 0.467 0.000
E24.8 Other Cushing's syndrome
0.528 0.472 0.000
E07 Other disorders of thyroid
0.527 0.473 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.514 0.486 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.514 0.486 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.514 0.486 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.514 0.486 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.514 0.486 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.514 0.486 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.514 0.486 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.514 0.486 0.000
E12.9 Without complications
0.514 0.486 0.000
E12.8 With unspecified complications
0.514 0.486 0.000
E12.7 With multiple complications
0.514 0.486 0.000
E12.6 With other specified complications
0.514 0.486 0.000
E12.5 With peripheral circulatory complications
0.514 0.486 0.000
E12.4 With neurological complications
0.514 0.486 0.000
E12.3 With ophthalmic complications
0.514 0.486 0.000
E12.2 With renal complications
0.514 0.486 0.000
E12.1 With ketoacidosis
0.514 0.486 0.000
E12.0 With coma
0.514 0.486 0.000
K75 Other inflammatory liver diseases
0.512 0.488 0.000
E23.2 Diabetes insipidus
0.505 0.495 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.500 0.500 0.000
E24.3 Ectopic ACTH syndrome
0.500 0.500 0.000
E24.1 Nelson's syndrome
0.500 0.500 0.000
E06.9 Thyroiditis, unspecified
0.498 0.502 0.000
E24.2 Drug-induced Cushing's syndrome
0.491 0.509 0.000
E30.9 Disorder of puberty, unspecified
0.481 0.518 0.000
E30.8 Other disorders of puberty
0.481 0.518 0.000
E30.1 Precocious puberty
0.481 0.518 0.000
E30.0 Delayed puberty
0.481 0.518 0.000
E32.9 Disease of thymus, unspecified
0.481 0.518 0.000
E32.8 Other diseases of thymus
0.481 0.518 0.000
E32.1 Abscess of thymus
0.481 0.518 0.000
E32.0 Persistent hyperplasia of thymus
0.481 0.518 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.481 0.518 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.481 0.518 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.481 0.518 0.000
E25.9 Adrenogenital disorder, unspecified
0.472 0.528 0.000
E25.8 Other adrenogenital disorders
0.472 0.528 0.000
E20.8 Other hypoparathyroidism
0.470 0.529 0.000
E20.1 Pseudohypoparathyroidism
0.470 0.529 0.000
E20.0 Idiopathic hypoparathyroidism
0.470 0.529 0.000
K75.8 Other specified inflammatory liver diseases
0.459 0.541 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.458 0.542 0.000
E53.8 Deficiency of other specified B group vitamins
0.456 0.544 0.000
E20.9 Hypoparathyroidism, unspecified
0.455 0.545 0.000
E28.3 Primary ovarian failure
0.447 0.552 0.000
E26.8 Other hyperaldosteronism
0.443 0.557 0.000
E26.1 Secondary hyperaldosteronism
0.443 0.557 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.438 0.562 0.000
E45 Retarded development following protein-energy malnutrition
0.438 0.562 0.000
E43 Unspecified severe protein-energy malnutrition
0.438 0.562 0.000
E42 Marasmic kwashiorkor
0.438 0.562 0.000
E41 Nutritional marasmus
0.438 0.562 0.000
E40 Kwashiorkor
0.438 0.562 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.438 0.562 0.000
E23.1 Drug-induced hypopituitarism
0.438 0.562 0.000
E53.1 Pyridoxine deficiency
0.429 0.571 0.000
E53.0 Riboflavin deficiency
0.429 0.571 0.000
E34 Other endocrine disorders
0.427 0.572 0.000
E24.9 Cushing's syndrome, unspecified
0.427 0.573 0.000
E10.5 With peripheral circulatory complications
0.423 0.577 0.000
E26.9 Hyperaldosteronism, unspecified
0.423 0.577 0.000
E50.9 Vitamin A deficiency, unspecified
0.421 0.579 0.000
E50.8 Other manifestations of vitamin A deficiency
0.421 0.579 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.421 0.579 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.421 0.579 0.000
E50.5 Vitamin A deficiency with night blindness
0.421 0.579 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.421 0.579 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.421 0.579 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.421 0.579 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.421 0.579 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.421 0.579 0.000
E63.9 Nutritional deficiency, unspecified
0.421 0.579 0.000
E63.8 Other specified nutritional deficiencies
0.421 0.579 0.000
E63.1 Imbalance of constituents of food intake
0.421 0.579 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.421 0.579 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.421 0.579 0.000
E64.8 Sequelae of other nutritional deficiencies
0.421 0.579 0.000
E64.3 Sequelae of rickets
0.421 0.579 0.000
E64.2 Sequelae of vitamin C deficiency
0.421 0.579 0.000
E64.1 Sequelae of vitamin A deficiency
0.421 0.579 0.000
E64.0 Sequelae of protein-energy malnutrition
0.421 0.579 0.000
E23.7 Disorder of pituitary gland, unspecified
0.418 0.582 0.000
E26.0 Primary hyperaldosteronism
0.413 0.587 0.000
E23.0 Hypopituitarism
0.412 0.588 0.000
E56.9 Vitamin deficiency, unspecified
0.409 0.591 0.000
E56.8 Deficiency of other vitamins
0.409 0.591 0.000
E56.0 Deficiency of vitamin E
0.409 0.591 0.000
E53.9 Vitamin B deficiency, unspecified
0.408 0.592 0.000
E07.8 Other specified disorders of thyroid
0.406 0.594 0.000
E51.9 Thiamine deficiency, unspecified
0.402 0.597 0.000
E51.8 Other manifestations of thiamine deficiency
0.402 0.597 0.000
E51.1 Beriberi
0.402 0.597 0.000
K70-K77 Diseases of liver
0.402 0.598 0.000
E61 Deficiency of other nutrient elements
0.393 0.607 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.392 0.608 0.000
E56.1 Deficiency of vitamin K
0.392 0.608 0.000
E29.8 Other testicular dysfunction
0.388 0.611 0.000
E29.0 Testicular hyperfunction
0.388 0.611 0.000
K73 Chronic hepatitis, not elsewhere classified
0.380 0.620 0.000
E07.1 Dyshormogenetic goitre
0.378 0.622 0.000
E07.0 Hypersecretion of calcitonin
0.378 0.622 0.000
E51.2 Wernicke's encephalopathy
0.377 0.623 0.000
E29.9 Testicular dysfunction, unspecified
0.377 0.623 0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.000 0.624 0.376
K75.3 Granulomatous hepatitis, not elsewhere classified
0.375 0.625 0.000
K72 Hepatic failure, not elsewhere classified
0.368 0.632 0.000
K75.2 Nonspecific reactive hepatitis
0.367 0.633 0.000
K75.1 Phlebitis of portal vein
0.367 0.633 0.000
K75.9 Inflammatory liver disease, unspecified
0.362 0.638 0.000
K72.0 Acute and subacute hepatic failure
0.358 0.642 0.000
K74 Fibrosis and cirrhosis of liver
0.349 0.651 0.000
K73.2 Chronic active hepatitis, not elsewhere classified
0.346 0.654 0.000
K75.0 Abscess of liver
0.345 0.655 0.000
E27.8 Other specified disorders of adrenal gland
0.343 0.656 0.001
K73.9 Chronic hepatitis, unspecified
0.333 0.667 0.000
E46 Unspecified protein-energy malnutrition
0.332 0.668 0.000
E04 Other non-toxic goitre
0.322 0.678 0.000
E44.1 Mild protein-energy malnutrition
0.314 0.686 0.000
E44.0 Moderate protein-energy malnutrition
0.314 0.686 0.000
E34.3 Short stature, not elsewhere classified
0.310 0.689 0.000
E23.6 Other disorders of pituitary gland
0.310 0.690 0.000
E34.5 Androgen resistance syndrome
0.306 0.693 0.000
E34.4 Constitutional tall stature
0.306 0.693 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.306 0.693 0.000
E34.1 Other hypersecretion of intestinal hormones
0.306 0.693 0.000
K74.5 Biliary cirrhosis, unspecified
0.302 0.698 0.000
K74.6 Other and unspecified cirrhosis of liver
0.300 0.700 0.000
K77 Liver disorders in diseases classified elsewhere
0.297 0.703 0.000
E21.2 Other hyperparathyroidism
0.290 0.710 0.000
K71 Toxic liver disease
0.287 0.713 0.000
E34.8 Other specified endocrine disorders
0.284 0.715 0.000
E04.0 Non-toxic diffuse goitre
0.284 0.716 0.000
E61.9 Deficiency of nutrient element, unspecified
0.282 0.718 0.000
E61.8 Deficiency of other specified nutrient elements
0.282 0.718 0.000
E61.7 Deficiency of multiple nutrient elements
0.282 0.718 0.000
E61.6 Vanadium deficiency
0.282 0.718 0.000
E61.5 Molybdenum deficiency
0.282 0.718 0.000
E61.4 Chromium deficiency
0.282 0.718 0.000
E61.3 Manganese deficiency
0.282 0.718 0.000
E61.0 Copper deficiency
0.282 0.718 0.000
E21.4 Other specified disorders of parathyroid gland
0.281 0.719 0.000
E22.0 Acromegaly and pituitary gigantism
0.280 0.719 0.001
E29.1 Testicular hypofunction
0.279 0.721 0.000
E34.0 Carcinoid syndrome
0.272 0.727 0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified
0.272 0.728 0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified
0.272 0.728 0.000
I83 Varicose veins of lower extremities
0.000 0.731 0.269
K73.8 Other chronic hepatitis, not elsewhere classified
0.265 0.735 0.000
K81.0 Acute cholecystitis
0.000 0.739 0.261
K72.1 Chronic hepatic failure
0.257 0.743 0.000
E21.0 Primary hyperparathyroidism
0.257 0.743 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.253 0.747 0.000
K74.4 Secondary biliary cirrhosis
0.250 0.750 0.000
K74.2 Hepatic fibrosis with hepatic sclerosis
0.250 0.750 0.000
K74.1 Hepatic sclerosis
0.250 0.750 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.249 0.751 0.000
E61.2 Magnesium deficiency
0.243 0.757 0.000
K74.3 Primary biliary cirrhosis
0.238 0.762 0.000
E04.8 Other specified non-toxic goitre
0.231 0.769 0.000
K71.0 Toxic liver disease with cholestasis
0.230 0.770 0.000
I83.1 Varicose veins of lower extremities with inflammation
0.000 0.773 0.227
K77.8 Liver disorders in other diseases classified elsewhere
0.222 0.778 0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation
0.000 0.784 0.216
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere
0.213 0.787 0.000
I83.0 Varicose veins of lower extremities with ulcer
0.000 0.787 0.213
E65-E68 Obesity and other hyperalimentation
0.208 0.788 0.005
K71.9 Toxic liver disease, unspecified
0.208 0.791 0.000
K71.8 Toxic liver disease with other disorders of liver
0.206 0.794 0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver
0.206 0.794 0.000
K71.5 Toxic liver disease with chronic active hepatitis
0.206 0.794 0.000
K71.4 Toxic liver disease with chronic lobular hepatitis
0.206 0.794 0.000
K71.3 Toxic liver disease with chronic persistent hepatitis
0.206 0.794 0.000
K71.2 Toxic liver disease with acute hepatitis
0.206 0.794 0.000
K74.0 Hepatic fibrosis
0.203 0.797 0.000
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
0.200 0.800 0.000
K71.1 Toxic liver disease with hepatic necrosis
0.190 0.810 0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified
0.189 0.811 0.000
E34.9 Endocrine disorder, unspecified
0.178 0.822 0.001
E21.3 Hyperparathyroidism, unspecified
0.176 0.824 0.000
E61.1 Iron deficiency
0.168 0.832 0.000
E04.2 Non-toxic multinodular goitre
0.153 0.847 0.000
E67 Other hyperalimentation
0.149 0.848 0.003
E68 Sequelae of hyperalimentation
0.149 0.848 0.003
K72.9 Hepatic failure, unspecified
0.150 0.850 0.000
E67.8 Other specified hyperalimentation
0.107 0.891 0.003
E67.3 Hypervitaminosis D
0.107 0.891 0.003
E67.2 Megavitamin-B6 syndrome
0.107 0.891 0.003
E67.1 Hypercarotenaemia
0.107 0.891 0.003
E67.0 Hypervitaminosis A
0.107 0.891 0.003
E07.9 Disorder of thyroid, unspecified
0.107 0.893 0.000
E04.1 Non-toxic single thyroid nodule
0.099 0.901 0.000
K76 Other diseases of liver
0.089 0.911 0.000
K76.9 Liver disease, unspecified
0.080 0.920 0.000
E14.9 Without complications
0.076 0.924 0.000
E04.9 Non-toxic goitre, unspecified
0.074 0.926 0.000
K70 Alcoholic liver disease
0.071 0.929 0.000
K76.5 Hepatic veno-occlusive disease
0.064 0.936 0.000
K76.4 Peliosis hepatis
0.064 0.936 0.000
K76.3 Infarction of liver
0.064 0.936 0.000
K76.2 Central haemorrhagic necrosis of liver
0.064 0.936 0.000
K90-K93 Other diseases of the digestive system
0.062 0.938 0.000
K76.1 Chronic passive congestion of liver
0.060 0.940 0.000
K70.0 Alcoholic fatty liver
0.058 0.942 0.000
K76.6 Portal hypertension
0.055 0.944 0.000
C85.1 B-cell lymphoma, unspecified
0.054 0.946 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.053 0.947 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.052 0.948 0.000
E83 Disorders of mineral metabolism
0.002 0.948 0.050
K76.7 Hepatorenal syndrome
0.051 0.949 0.000
E11 Non-insulin-dependent diabetes mellitus
0.047 0.953 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.045 0.955 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.042 0.958 0.000
E65 Localised adiposity
0.033 0.958 0.009
M35.0 Sicca syndrome [Sjogren]
0.041 0.959 0.000
K70.4 Alcoholic hepatic failure
0.040 0.960 0.000
E11.6 With other specified complications
0.040 0.960 0.000
K70.9 Alcoholic liver disease, unspecified
0.040 0.960 0.000
K70.2 Alcoholic fibrosis and sclerosis of liver
0.039 0.961 0.000
K70.1 Alcoholic hepatitis
0.038 0.962 0.000
G20 Parkinson's disease
0.000 0.962 0.038
C85.0 Lymphosarcoma
0.038 0.962 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.002 0.962 0.036
E83.8 Other disorders of mineral metabolism
0.002 0.962 0.036
E83.2 Disorders of zinc metabolism
0.002 0.962 0.036
E83.0 Disorders of copper metabolism
0.002 0.962 0.036
E11.8 With unspecified complications
0.037 0.963 0.000
E11.7 With multiple complications
0.036 0.963 0.000
E11.1 With ketoacidosis
0.036 0.964 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.036 0.964 0.000
K81 Cholecystitis
0.000 0.965 0.035
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.032 0.967 0.000
K93.1 Megacolon in Chagas' disease
0.032 0.967 0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.032 0.967 0.000
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.000 0.968 0.032
G20-G26 Extrapyramidal and movement disorders
0.000 0.970 0.030
G25.8 Other specified extrapyramidal and movement disorders
0.000 0.973 0.027
G25 Other extrapyramidal and movement disorders
0.000 0.973 0.027
G24 Dystonia
0.000 0.973 0.027
C83.3 Large cell (diffuse)
0.026 0.974 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.024 0.976 0.000
K81.8 Other cholecystitis
0.000 0.976 0.024
E83.3 Disorders of phosphorus metabolism
0.001 0.976 0.022
C83 Diffuse non-Hodgkin's lymphoma
0.023 0.977 0.000
G21 Secondary Parkinsonism
0.000 0.977 0.023
G24.3 Spasmodic torticollis
0.000 0.978 0.022
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.000 0.978 0.022
G22 Parkinsonism in diseases classified elsewhere
0.000 0.978 0.022
G25.3 Myoclonus
0.000 0.978 0.022
G24.8 Other dystonia
0.000 0.978 0.022
G23 Other degenerative diseases of basal ganglia
0.000 0.979 0.021
E11.0 With coma
0.021 0.979 0.000
G25.5 Other chorea
0.000 0.979 0.021
E11.5 With peripheral circulatory complications
0.021 0.979 0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.021 0.979 0.000
G24.5 Blepharospasm
0.000 0.980 0.020
E11.2 With renal complications
0.020 0.980 0.000
C95 Leukaemia of unspecified cell type
0.020 0.980 0.000
C88 Malignant immunoproliferative diseases
0.020 0.980 0.000
C86 Other specified types of T/NK-cell lymphoma
0.019 0.980 0.000
G25.6 Drug-induced tics and other tics of organic origin
0.000 0.980 0.019
G25.4 Drug-induced chorea
0.000 0.980 0.019
G25.1 Drug-induced tremor
0.000 0.981 0.019
G24.9 Dystonia, unspecified
0.000 0.981 0.019
G24.4 Idiopathic orofacial dystonia
0.000 0.981 0.019
G24.2 Idiopathic nonfamilial dystonia
0.000 0.981 0.019
G24.1 Idiopathic familial dystonia
0.000 0.981 0.019
G24.0 Drug-induced dystonia
0.000 0.981 0.019
K81.1 Chronic cholecystitis
0.000 0.981 0.019
G25.9 Extrapyramidal and movement disorder, unspecified
0.000 0.981 0.019
C83.7 Burkitt's tumour
0.018 0.981 0.000
E66 Obesity
0.016 0.981 0.003
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.018 0.982 0.000
C91 Lymphoid leukaemia
0.018 0.982 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.018 0.982 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.018 0.982 0.000
C94 Other leukaemias of specified cell type
0.018 0.982 0.000
Chapter XI Diseases of the digestive system
0.018 0.982 0.000
C95.9 Leukaemia, unspecified
0.018 0.982 0.000
G21.1 Other drug-induced secondary Parkinsonism
0.000 0.983 0.017
C93 Monocytic leukaemia
0.017 0.983 0.000
E83.4 Disorders of magnesium metabolism
0.001 0.983 0.016
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.017 0.983 0.000
K50.0 Crohn's disease of small intestine
0.000 0.983 0.017
C83.6 Undifferentiated (diffuse)
0.017 0.983 0.000
C83.5 Lymphoblastic (diffuse)
0.017 0.983 0.000
C83.4 Immunoblastic (diffuse)
0.017 0.983 0.000
C83.2 Mixed small and large cell (diffuse)
0.017 0.983 0.000
K50 Crohn's disease [regional enteritis]
0.000 0.983 0.017
G21.9 Secondary Parkinsonism, unspecified
0.000 0.983 0.016
G21.8 Other secondary Parkinsonism
0.000 0.983 0.016
G21.4 Vascular parkinsonism
0.000 0.983 0.016
G21.3 Postencephalitic Parkinsonism
0.000 0.983 0.016
G21.2 Secondary Parkinsonism due to other external agents
0.000 0.983 0.016
G21.0 Malignant neuroleptic syndrome
0.000 0.983 0.016
K50.1 Crohn's disease of large intestine
0.000 0.984 0.016
E11.3 With ophthalmic complications
0.016 0.984 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.016 0.984 0.000
K50.8 Other Crohn's disease
0.000 0.984 0.016
G23.9 Degenerative disease of basal ganglia, unspecified
0.000 0.984 0.015
G23.3 Multiple system atrophy, cerebellar type
0.000 0.984 0.015
G23.2 Striatonigral degeneration
0.000 0.984 0.015
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
0.000 0.984 0.015
G23.0 Hallervorden-Spatz disease
0.000 0.984 0.015
K46.9 Unspecified abdominal hernia without obstruction or gangrene
0.000 0.985 0.015
K70.3 Alcoholic cirrhosis of liver
0.015 0.985 0.000
N05.9 Unspecified
0.015 0.985 0.000
G23.8 Other specified degenerative diseases of basal ganglia
0.000 0.985 0.015
C91.4 Hairy-cell leukaemia
0.015 0.985 0.000
K13.0 Diseases of lips
0.000 0.985 0.015
C88.9 Malignant immunoproliferative disease, unspecified
0.014 0.986 0.000
C88.7 Other malignant immunoproliferative diseases
0.014 0.986 0.000
C88.3 Immunoproliferative small intestinal disease
0.014 0.986 0.000
C88.2 Gamma heavy chain disease
0.014 0.986 0.000
C88.1 Alpha heavy chain disease
0.014 0.986 0.000
C95.7 Other leukaemia of unspecified cell type
0.014 0.986 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.014 0.986 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.014 0.986 0.000
C86.4 Blastic NK-cell lymphoma
0.014 0.986 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.014 0.986 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.014 0.986 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.014 0.986 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.014 0.986 0.000
C81 Hodgkin's disease
0.014 0.986 0.000
C91.0 Acute lymphoblastic leukaemia
0.014 0.986 0.000
N05 Unspecified nephritic syndrome
0.014 0.986 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.014 0.986 0.000
C95.0 Acute leukaemia of unspecified cell type
0.014 0.986 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.014 0.986 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.014 0.986 0.000
C84.5 Other and unspecified T-cell lymphomas
0.014 0.986 0.000
N05.2 Diffuse membranous glomerulonephritis
0.014 0.986 0.000
E66.1 Drug-induced obesity
0.011 0.986 0.002
C91.5 Adult T-cell leukaemia
0.013 0.987 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.987 0.013
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.987 0.013
C91.8 Mature B-cell leukaemia Burkitt-type
0.013 0.987 0.000
C91.7 Other lymphoid leukaemia
0.013 0.987 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.013 0.987 0.000
C91.3 Prolymphocytic leukaemia
0.013 0.987 0.000
C91.2 Subacute lymphocytic leukaemia
0.013 0.987 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.013 0.987 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.013 0.987 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.013 0.987 0.000
C84.3 Lymphoepithelioid lymphoma
0.013 0.987 0.000
C84.2 T-zone lymphoma
0.013 0.987 0.000
C84.1 Sezary's diease
0.013 0.987 0.000
K50.9 Crohn's disease, unspecified
0.000 0.987 0.013
C95.1 Chronic leukaemia of unspecified cell type
0.013 0.987 0.000
C91.9 Lymphoid leukaemia, unspecified
0.013 0.987 0.000
C94.7 Other specified leukaemias
0.013 0.987 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.013 0.987 0.000
C94.5 Acute myelofibrosis
0.013 0.987 0.000
C94.4 Acute panmyelosis
0.013 0.987 0.000
C94.3 Mast cell leukaemia
0.013 0.987 0.000
C94.2 Acute megakaryoblastic leukaemia
0.013 0.987 0.000
C94.1 Chronic erythraemia
0.013 0.987 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.013 0.987 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.013 0.987 0.000
C96.8 Histiocytic sarcoma
0.013 0.987 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.013 0.987 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.013 0.987 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.013 0.987 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.013 0.987 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.